UEEC Pengajuan SEC - United Health Products, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

1096938

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to United Health Products, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 14, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
June 16, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2025 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissio
May 8, 2025	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2025 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commission
May 8, 2025	EX-99.1	United Health Products Announces OTCQB Uplisting and FDA Update EXHIBIT 99.1 United Health Products Announces OTCQB Uplisting and FDA Update Mount Laurel, New Jersey – May 1, 2025 – United Health Products, Inc. (OTCQB: UEEC) is pleased to announce that it has been approved to have its common shares uplisted from the OTC “Pink” market to the OTCQB Venture Market (“OTCQB”). The successful uplisting is effective May 1, 2025 and the company’s common shares will co
May 5, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
March 28, 2025	EX-19	Insider Trading Policy EXHIBIT 19 United Health Products, Inc. - Insider Trading Policy This Insider Trading Policy provides guidelines to all employees and officers of United Health Products, Inc. (the “Company”) as well as members of the Company’s Board of Directors (the “Directors”) with respect to transactions in the Company’s securities and codifies the Company’s standards on trading and enabling the trading of sec
March 28, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED: DECEMBER 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS,
December 4, 2024	SC 13D/A	UEEC / United Health Products, Inc. / BEPLATE DOUGLAS K - SC 13D/A Activist Investment SC 13D/A 1 ueecsc13da.htm SC 13D/A UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* United Health Products, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 91059D100 (CUSIP Number) Douglas K. Beplate, P.O. Box #407, 1777 South Burlington Blvd., Bur
November 12, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODU
November 6, 2024	EX-99.1	United Health Products Provides Update on FDA PMA Application EXHIBIT 99.1 United Health Products Provides Update on FDA PMA Application Mount Laurel, New Jersey – November 4, 2024 – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s August 15, 2024 submission of its Submission Issue Request (SIR) to the FDA which responded to certain questions in the
November 6, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2024 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commis
August 20, 2024	424B3	UNITED HEALTH PRODUCTS, INC. Up to 15,000,000 Shares of Common Stock for Resale by the Selling Security Holder Filed Pursuant to Rule 424(b)(3) Registration No. 333-280504 PROSPECTUS SUPPLEMENT NO. 1 (To Prospectus Dated July 29, 2024) UNITED HEALTH PRODUCTS, INC. Up to 15,000,000 Shares of Common Stock for Resale by the Selling Security Holder This prospectus supplement No. 1 is being filed to update, amend and supplement the prospectus dated July 29, 2024 (the “Prospectus”), relating to the offering and
August 13, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
August 1, 2024	424B3	UNITED HEALTH PRODUCTS, INC. 15,000,000 Shares of Common Stock for Resale by the Selling Security Holder Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-280504 PROSPECTUS UNITED HEALTH PRODUCTS, INC. 15,000,000 Shares of Common Stock for Resale by the Selling Security Holder This prospectus relates to the offer and resale of up to 15,000,000 shares of our common stock, par value $0.001 per share (“Common Stock”), that we may issue to White Lion Capital, LLC, from and after the date of
July 26, 2024	CORRESP	United Health Products, Inc 520 Fellowship Road, Suite #D-406 Mt. Laurel, NJ 08054 United Health Products, Inc 520 Fellowship Road, Suite #D-406 Mt. Laurel, NJ 08054 July 26, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. St., N.E. Washington, D.C. 20549 Re: Request for Acceleration of Effectiveness of Registration Statement on Form S-1 (File No. 333-280504) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Ac
July 25, 2024	S-1/A	As filed with the Securities and Exchange Commission on July 25, 2024 As filed with the Securities and Exchange Commission on July 25, 2024 Registration No.
July 22, 2024	S-1/A	As filed with the Securities and Exchange Commission on July 22, 2024 As filed with the Securities and Exchange Commission on July 22, 2024 Registration No.
July 15, 2024	S-1/A	As filed with the Securities and Exchange Commission on July 15, 2024 As filed with the Securities and Exchange Commission on July 15, 2024 Registration No.
June 26, 2024	S-1	As filed with the Securities and Exchange Commission on June 26, 2024 As filed with the Securities and Exchange Commission on June 26, 2024 Registration No.
June 26, 2024	EX-FILING FEES	Filing Fee Table EXHIBIT 107 Calculation of Filing Fee Tables Form S-1 (Form Type) United Health Products, Inc.
June 26, 2024	EX-4.2	Form of Amendment to Convertible Promissory Note Subscription Agreement EXHIBIT 4.2 AMENDMENT TO CONVERTIBLE NOTE SUBSCRIPTION AGREEMENT This AMENDMENT TO CONVERTIBLE NOTE SUBSCRIPTION AGREEMENT (this “Amendment”) is dated as of December [●], 2023 by and between United Health Products, Inc. (“Company”) and [●] (“Investor”). Company and Investor are each sometimes referred to herein individually as a “Party” and together as the “Parties.” W I T N E S S E T H WHEREAS, C
June 26, 2024	EX-4.1	Form of Convertible Promissory Note Subscription Agreement EXHIBIT 4.1 SUBSCRIPTION AGREEMENT United Health Products, Inc. [●] [●] Ladies and Gentlemen: United Health Products, Inc., a Nevada corporation (the “Company”) is pursuing an offering (the “Offering”) of Unsecured Convertible Notes bearing interest at the rate of ten percent (10%) per annum (the “Notes”) and offered at an original issue discount of seven percent (7%) (the ‘OID”). The undersigned
June 25, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissio
June 25, 2024	EX-10.1	Second Amendment to Stock Purchase Agreement dated June 20, 2024 (11) EXHIBIT 10.1 AMENDMENT NO. 2 TO COMMON STOCK PURCHASE AGREEMENT Reference is made to that certain Common Stock Purchase Agreement (the “Agreement”) dated September 1, 2022 by and between United Health Products, Inc., a Nevada corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”). The Company and the Investor hereby agree to amend the Agreemen
May 9, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
April 1, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
November 13, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODU
August 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
June 12, 2023	EX-FILING FEES	Filing Fee Table EXHIBIT 107 Calculation of Filing Fee Tables Form S-8 (Form Type) United Health Products, Inc.
June 12, 2023	S-8	As filed with the Securities and Exchange Commission on June 12, 2023 As filed with the Securities and Exchange Commission on June 12, 2023 Registration No.
June 12, 2023	EX-99.2	Employment Agreement with Gerard Abate EXHIBIT 99.2
June 12, 2023	EX-99.1	Employment Agreement with John Phillips EXHIBIT 99.1
May 8, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
March 28, 2023	EX-10.11	Amendment to Stock Purchase Agreement dated January 25, 2023 (10) EXHIBIT 10.11 AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT Reference is made to that certain Common Stock Purchase Agreement (the “Agreement”) dated September 1, 2022 by and between United Health Products, Inc., a Nevada corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”). The Company and the Investor hereby agree to amend the Agreement as
March 28, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 COMMISSION FILE NUMBER: 000-27781 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
January 31, 2023	EX-99.1	United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement EXHIBIT 99.1 United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement Mesquite, Nevada – January 31, 2023 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application process and the amendment of its Agreement with White Lion Capital. UHP continues to advance its Premarket Approval applic
January 31, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2023 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commis
November 14, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODU
October 20, 2022	S-8	As filed with the Securities and Exchange Commission on October 20, 2022 As filed with the Securities and Exchange Commission on October 20, 2022 Registration No.
October 20, 2022	EX-FILING FEES	Filing Fee Table EXHIBIT 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) United Health Products, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1 ? Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stoc
September 23, 2022	424B3	UNITED HEALTH PRODUCTS, INC. 15,000,000 Shares of Common Stock of United Health Products, Inc. PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-267310 UNITED HEALTH PRODUCTS, INC. 15,000,000 Shares of Common Stock of United Health Products, Inc. This prospectus relates to the offer and resale of up to 15,000,000 shares of our Common Stock, par value $0.001 per share, comprised of: (i) 757,576 shares of our common stock that we issued to White Lion Capital, LLC as Commitment
September 15, 2022	CORRESP	United Health Products, Inc. 526 Commerce Circle, STE #102 Mesquite, Nevada 89027 United Health Products, Inc. 526 Commerce Circle, STE #102 Mesquite, Nevada 89027 September 15, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. St., N.E. Washington, D.C. 20549 Re: Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-267310) of United Health Products, Inc. (the ?Registrant?) Ladies and
September 7, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2022 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commi
September 7, 2022	EX-10.1	Stock Purchase Agreement dated September 1, 2022 between the Company and White Lion Capital LLC (9) EXHIBIT 10.1 COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement is entered into as of September 1, 2022 (this ?Agreement?), by and between United Health Products, Inc., a Nevada corporation (the ?Company?), and White Lion Capital, LLC, a Nevada limited liability company (the ?Investor?). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained here
September 7, 2022	S-3	As filed with the Securities and Exchange Commission on September 7, 2022 As filed with the Securities and Exchange Commission on September 7, 2022 Registration No.
September 7, 2022	EX-99.1	United Health Products Announces Equity Financing Agreement and Provides Corporate Update EXHIBIT 99.1 United Health Products Announces Equity Financing Agreement and Provides Corporate Update Mesquite, Nevada ? September 6, 2022 ? United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sell up to $10 million of shares to White Lion Capital, LLC (White Lion), a California-based institutional investor. Under the ter
September 7, 2022	EX-FILING FEES	Filing Fee Table EXHIBIT 107 Calculation of Filing Fee Tables Form S-3 (Form Type) United Health Products, Inc.
August 15, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
July 19, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2022 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissio
July 19, 2022	EX-99.1	United Health Products Provides Update on FDA Review EXHIBIT 99.1 United Health Products Provides Update on FDA Review Henderson, Nevada ? July 15, 2022 ? United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company?s FDA Premarket Approval application. On July 13 the company and its regulatory consultant met with the full FDA team assigned to review its Class III PMA application. The focus of the meeting was to discuss
June 23, 2022	EX-10.2	Amendment to Brian Thom November 24, 2020 RSU Agreement EXHIBIT 10.2 AMENDMENT TO NOVEMBER 24, 2020 RSU AGREEMENT This amendment to the Restricted Stock Agreement dated November 24th, 2020 (this ?Amendment?) is dated as of June 17, 2022, by and between United Health Products, Inc. (the ?Company?) and Brian Thom (?Grantee?). The Company and Grantee are each sometimes referred to herein individually as a ?Party? and together as the ?Parties.? W I T N E S
June 23, 2022	EX-99.1	United Health Products Announces Settlement of SEC Investigation EXHIBIT 99.1 United Health Products Announces Settlement of SEC Investigation Henderson, Nevada ? June 16, 2022 ? United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021. UHP has agreed with the Securities and Exchange Commission (the Commis
June 23, 2022	EX-10.3	Robert Denser Restricted Stock Unit Agreement dated June 17, 2022 EXHIBIT 10.3 Restricted Stock Unit Agreement This Restricted Stock Unit Agreement (this ?Agreement?) is made and entered into as of June 17, 2022 (the ?Grant Date?) by and between UNITED HEALTH PRODUCTS INC., a Nevada corporation (the ?Company?) and ROBERT DENSER (the ?Grantee?). WHEREAS, the Board of Directors of the Company (the ?Board?) has determined that it is in the best interests of the Com
June 23, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2022 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissio
June 10, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2022 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commission
June 3, 2022	S-8	As filed with the Securities and Exchange Commission on June 3, 2022 As filed with the Securities and Exchange Commission on June 3, 2022 Registration No.
June 3, 2022	EX-FILING FEES	Filing Fee Table EXHIBIT 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) United Health Products, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1 ? Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common stoc
May 16, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
April 29, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2022 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissi
April 1, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 COMMISSION FILE NUMBER: 000-27781 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
April 1, 2022	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number 000-27781 CUSIP Number 91059D100 (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Tra
February 24, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2022 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commi
January 4, 2022	S-8	As filed with the Securities and Exchange Commission on January 4, 2022 As filed with the Securities and Exchange Commission on January 4, 2022 Registration No.
December 10, 2021	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2021 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commi
November 5, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODU
October 14, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2021 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commis
October 14, 2021	EX-99.1	United Health Products Provides Business Update EXHIBIT 99.1 United Health Products Provides Business Update Henderson, Nevada ? October 7, 2021 ? United Health Products, Inc. (OTCPK: UEEC), (UHP), developer, manufacturer and marketer of HemoStyp?, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today provided an update on its regulatory approval application process and other business activities. As part of its su
October 14, 2021	EX-99.2	Investor Presentation EXHIBIT 99.2
September 29, 2021	CORRESP	September 29, 2021 September 29, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F.
September 28, 2021	S-3/A	As filed with the Securities and Exchange Commission on September 28, 2021 As filed with the Securities and Exchange Commission on September 28, 2021 Registration No.
August 16, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
June 29, 2021	S-3	As filed with the Securities and Exchange Commission on June 29, 2021 As filed with the Securities and Exchange Commission on June 29, 2021 Registration No.
June 28, 2021	EX-99.1	United Health Products Provides Corporate Update and Announces Equity Financing EXHIBIT 99.1 United Health Products Provides Corporate Update and Announces Equity Financing ? Initiation of laparoscopic study to expand potential Class III indications for HemoStyp? gauze ? Latest animal study demonstrates proof of concept and comparative performance of HemoStyp Gel format ? Discussions underway for clinical study to evaluate HemoStyp adhesive bandage benefits in hemodialysis ap
June 28, 2021	EX-10.1	Common Stock Purchase Agreement, dated June 25, 2021 between Company and Triton Funds LP (4) EXHIBIT 10.1 COMMON STOCK PURCHASE AGREEMENT This common stock purchase agreement (the ?Agreement?), dated as of June 25, 2021 (the ?Execution Date?), is entered into between United Health Products, Inc., a Nevada corporation (the ?Company?), and TRITON FUNDS LP, a Delaware limited partnership (the ?Investor?). RECITALS: WHEREAS, upon the terms and subject to the conditions contained herein, the I
June 28, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2021 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissio
May 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
May 5, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2021 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commission
May 5, 2021	EX-99.1	United Health Products’ HemoStyp EXHIBIT 99.1 United Health Products? HemoStyp? Gauze Advances to FDA Substantive Review Process Henderson, Nevada ? May 5, 2021 ? United Health Products, Inc. (OTCPK: UEEC), (?UHP? or the ?Company?), developer, manufacturer and marketer of HemoStyp?, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent, received notification this week from the Food & Drug Administration (FDA) tha
March 30, 2021	10-K	Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
January 15, 2021	SC 13D	UNITED STATES UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D.
January 11, 2021	EX-10.2	Services Agreement with Kristofer Heaton (7) EXHIBIT 10.2 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (this “Agreement”) dated as of December [ ], 2020, by and between UNITED HEALTH PRODUCTS, INC., a Nevada corporation (“Company”) and KRISTOFER HEATON (“Employee”). W I T N E S S E T H: WHEREAS, Company desires to engage the services of Employee and Employee desires to provide the services to Company in connection with Company’s business; and W
January 11, 2021	EX-10.3	Amendment to Restricted Stock Unit Agreement – Brian Thom (8) EXHIBIT 10.3 Second Restricted Stock Unit Agreement This Second Restricted Stock Unit Agreement (this "Agreement") is made and entered into as of December 31, 2020 (the “Initial Grant Date”) by and between UNITED HEALTH PRODUCTS INC., a Nevada corporation (the "Company") and KRISTOFER HEATON (the "Grantee"). WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in
January 11, 2021	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 11, 2021 (Date of earliest event reported: January 6, 2021) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incor
January 11, 2021	EX-10.1	Services Agreement with Kristofer Heaton (9) EXHIBIT 10.1 SECOND AMENDMENT TO MARCH 25, 2019 RSU AGREEMENT This AMENDMENT TO RESTRICTED STOCK UNIT AGREEMENT (this “Amendment”) is dated as of January 6, 2021, by and between United Health Products, Inc. (“United Health” or the “Company”) and Douglas Beplate (“Grantee”). United Health and Douglas Beplate are each sometimes referred to herein individually as a “Party” and together as the “Partie
December 1, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: Date of earliest event: December 1, 2020 (November 24, 2020) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporatio
December 1, 2020	EX-10.2	Restricted Stock Unit Agreement - Brian Thom (6) EXHIBIT 10.2
December 1, 2020	EX-99.1	United Health Products Announces Leadership Changes EXHIBIT 99.1 United Health Products Announces Leadership Changes Henderson, Nevada – November 24, 2020 – United Health Products, Inc. (OTC: UEEC), (“UHP” or the company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced changes to its senior management team and its Board of Directors. Douglas Beplate,
December 1, 2020	EX-10.1	Services Agreement with Brian Thom (6) EXHIBIT 10.1
November 13, 2020	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODU
November 3, 2020	CORRESP	- November 3, 2020 Mr. Kevin Kuhar Accounting Branch Chief Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission Washington, D.C. 20549 Re: United Health Products, Inc. (the “Company”) Form 10-K for the Fiscal Year Ended December 31, 2019 Filed July 9, 2020 File No. 000-27781 Dear Mr. Kuhar: The Company is in receipt of your comment letter dated September 29
October 22, 2020	144	- FORM 144 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 SEC USE ONLY NOTICE OF PROPOSED SALE OF SECURITIES DOCUMENT SEQUENCE NO. PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 CUSIP NUMBER ATTENTION: Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker WORK
August 7, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
July 20, 2020	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
July 9, 2020	10-K	Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2019 COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
May 22, 2020	8-K/A	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissi
May 14, 2020	NT 10-K	- NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2019 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report o
May 14, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commission
April 8, 2020	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2020 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissi
April 2, 2020	EX-16	Letter from Haynie & Company dated March 31, 2020 EXHIBIT 16
April 2, 2020	8-K/A	Financial Statements and Exhibits, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2020 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of inco
March 31, 2020	8-K	Financial Statements and Exhibits, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2020 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commissi
December 23, 2019	8-K	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2019 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commi
December 23, 2019	EX-16	Letter re: change in certifying accountant. EXHIBIT 16
November 1, 2019	EX-99.1	2019 Employee Benefit and Consulting Services Compensation Plan (12) EXHIBIT 99.1 UNITED HEALTH PRODUCTS, INC. 2019 EMPLOYEE BENEFIT AND CONSULTING SERVICES COMPENSATION PLAN SECTION 1. INTRODUCTION 1.1 Establishment. United Health Products, Inc., a Nevada corporation (the “Company”), hereby establishes a plan of long-term stock-based compensation incentives for selected Eligible Participants (defined below) of the Company and its affiliated corporations. This plan
November 1, 2019	S-8	UEEC / United Health Products, Inc. S-8 - - FORM S-8 As filed with the Securities and Exchange Commission on November 1, 2019. Registration No. 333- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 UNITED HEALTH PRODUCTS, INC. (Exact Name of Issuer as specified in its Charter) Nevada 84-1517723 (State of other Jurisdiction (I.R.S. Employer Incorporation or Organization) Identi
November 1, 2019	10-Q	UEEC / United Health Products, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODU
October 9, 2019	EX-99.1	United Health Products Files Defamation Lawsuit Against Short Sellers EXHIBIT 99.1 United Health Products Files Defamation Lawsuit Against Short Sellers Henderson, Nevada – October 8, 2019 – United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose, today announced it has filed a defamation, trade libel and unlawful and deceptive practices lawsuit against White Diamond Research LLC,
October 9, 2019	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2019 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commiss
September 6, 2019	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: Date of earliest event: September 6, 2019 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commission File
August 21, 2019	10-Q/A	UEEC / United Health Products, Inc. 10-Q/A - Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED
August 14, 2019	10-Q	UEEC / United Health Products, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
May 22, 2019	10-Q/A	UEEC / United Health Products, Inc. 10-Q/A - Quarterly Report - FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNI
May 15, 2019	10-Q	UEEC / United Health Products, Inc. 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
April 1, 2019	10-K	UEEC / United Health Products, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
April 1, 2019	EX-10.4	Restricted Stock Unit Agreement – Louis Schiliro (5) EXHIBIT 10.4 Restricted Stock Unit Agreement This Restricted Stock Unit Agreement (this “Agreement”) is made and entered into as of March 25, 2019 (the “Grant Date”) by and between UNITED HEALTH PRODUCTS INC., a Nevada corporation (the “Company”) and LOUIS SCHILIRO (the “Grantee”). WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the C
April 1, 2019	EX-10.5	Restricted Stock Unit Agreement – Doug Beplate (5) EXHIBIT 10.5 Restricted Stock Unit Agreement This Restricted Stock Unit Agreement (this “Agreement”) is made and entered into as of March 25, 2019 (the “Grant Date”) by and between UNITED HEALTH PRODUCTS INC., a Nevada corporation (the “Company”) and DOUGLAS BEPLATE (the “Grantee”). WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the
November 19, 2018	10-Q	UEEC / United Health Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODU
November 15, 2018	NT 10-Q	UEEC / United Health Products, Inc. NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form10K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on
October 1, 2018	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 1, 2018 (Date of earliest event reported: September 24, 2018) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of inc
August 20, 2018	EX-10.3	Services Agreement with Louis Schiliro (4) EXHIBIT 10.3 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (this “Agreement”) dated as of January 1, 2018, by and between UNITED HEALTH PRODUCTS, INC., a Nevada corporation (“Company”) and Louis Schiliro (“Employee”). W I T N E S S E T H: WHEREAS, Company desires to engage the services of Employee and Employee desires to provide the services to Company in connection with Company’s business; and WHEREA
August 20, 2018	10-Q	UEEC / United Health Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
August 14, 2018	NT 10-Q	UEEC / United Health Products, Inc. NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Fo
July 26, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 26, 2018 (Date of earliest event reported: July 25, 2018) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporat
May 21, 2018	10-Q	UEEC / United Health Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-27781 UNITED HEALTH PRODUCTS,
May 16, 2018	NT 10-Q	UEEC / United Health Products, Inc. NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2018 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on F
April 17, 2018	10-K	UEEC / United Health Products, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017 COMMISSION FILE NUMBER: 000-27781 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
April 2, 2018	EX-99.1	PRITCHETT, SILER & HARDY, P.C. CERTIFIED PUBLIC ACCOUNTANTS A PROFESSIONAL CORPORATION 515 South 400 East, Suite 100 Salt Lake City, UT 84111 (801) 328-2727 FAX (801) 328-1123 EXHIBIT 99.1 PRITCHETT, SILER & HARDY, P.C. CERTIFIED PUBLIC ACCOUNTANTS A PROFESSIONAL CORPORATION 515 South 400 East, Suite 100 Salt Lake City, UT 84111 (801) 328-2727 FAX (801) 328-1123 March 29, 2018 The Board of Directors United Health Products, Inc. 10624 S. Eastern Avenue, STE A209 Henderson, NV 89052 The purpose of this letter is to inform you that Haynie & Company CPA’s, a leading regiona
April 2, 2018	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 2, 2018 (Date of earliest event reported: March 29, 2018) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorpora
April 2, 2018	EX-16.1	Letter from Pritchett, Siler and Hardy P.C. dated March 29, 2018 EXHIBIT 16.1 March 29, 2018 U.S. Securities and Exchange Commission 100 F. Street Washington, DC 20549 – 7561 Ladies and Gentlemen: Re: United Health Products, Inc. Commission File No. 000- 27781 We have read the statements of the Company pertaining to our firm included in Item 4.01 of the Form 8-K dated March 29, 2018 and are in agreement with the statements contained in that document pertaining
March 30, 2018	NT 10-K	UEEC / United Health Products, Inc. NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 12/31/2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form N
March 19, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report, (Date of earliest event reported): March 19, 2018 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorporation) (Commiss
March 19, 2018	EX-99.1	United Health Products Forms Medical Advisory Board EXHIBIT 99.1 United Health Products Forms Medical Advisory Board March 19, 2018 08:30 ET HENDERSON, Nev., March 19, 2018 (GLOBE NEWSWIRE) - United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, is pleased to announce the formation of a Medical Advisory Board. Joining this newly formed Board are:
December 5, 2017	EX-99.1	FDA Selects HemoStyp® for CtQ Pilot Program ueecex991.htm EXHIBIT 99.1 FDA Selects HemoStyp? for CtQ Pilot Program Henderson, Nevada ? December 4, 2017 ?United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp?, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it is proceeding with its application for HemoStyp under the FDA?s new and innovative CtQ Pilot Program. The FD
December 5, 2017	8-K	Regulation FD Disclosure, Financial Statements and Exhibits ueec8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report, (Date of earliest event reported): December 5, 2017 (December 4, 2017) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdi
November 14, 2017	10-Q	UEEC / United Health Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODU
August 21, 2017	10-Q	UEEC / United Health Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
August 15, 2017	NT 10-Q	United Health Products NT 10-Q ueecnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transitio
July 31, 2017	10-Q	UEEC / United Health Products, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
June 1, 2017	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016 COMMISSION FILE NUMBER: 814-00717 UNI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
March 31, 2017	NT 10-K	United Health Products NT 10-K ueecnt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 12/31/2016 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition R
March 6, 2017	8-K	Other Events ueec8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report, (Date of earliest event reported): March 6, 2017 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporation
November 21, 2016	10-Q	United Health Products FORM 10-Q (Quarterly Report) ueec10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED
November 14, 2016	NT 10-Q	United Health Products NT 10-Q ueecnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2016 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Tran
August 23, 2016	10-Q	United Health Products FORM 10-Q (Quarterly Report) ueec10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number:814-00717 UNITED HEALTH
August 19, 2016	EX-16.1	EX-16.1 ueecex161.htm EXHIBIT 16.1
August 19, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant ueec8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 19, 2016 (Date of earliest event reported: August 18, 2016) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdictio
August 16, 2016	NT 10-Q	United Health Products NT 10-Q ueecnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2016 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transitio
August 16, 2016	NT 10-Q	United Health Products NT 10-Q ueecnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2016 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transitio
June 15, 2016	10-Q	United Health Products FORM 10-Q (Quarterly Report) ueec10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number:814-00717 UNITED HEALT
May 17, 2016	NT 10-Q	United Health Products NT 10-Q ueecnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 3/31/2016 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Re
May 13, 2016	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRO
May 13, 2016	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 COMMISSION FILE NUMBER: 814-00717 UNI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organiza
May 13, 2016	EX-10.5	United Health Products, Inc. 10624 S. Eastern Ave., Ste. A209 Henderson, NV 89052 Tel: 877-358-3444 June 25, 2015 EXHIBIT 10.5 United Health Products, Inc. 10624 S. Eastern Ave., Ste. A209 Henderson, NV 89052 Tel: 877-358-3444 June 25, 2015 Dr. Philip Forman Dear Dr. Forman: Your employment agreement of November 10, 2014 is amended as follows. (Note: The sections of the employment agreement not listed below remain unchanged.) Section 1 ? Employment Employee agrees to serve as a medical advisor of the Company
May 13, 2016	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number:814-00717 UNITED HEALTH PRODUCTS
May 13, 2016	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number:814-00717 UNITED HEALTH PRODUCTS,
March 30, 2016	NT 10-K	United Health Products NT 10-K ueecnt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 12/31/2015 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition R
November 23, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODU
November 16, 2015	NT 10-Q	United Health Products NT 10-Q ueecnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form10K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 09/30/2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Rep
August 19, 2015	EX-10.5	2013 Employee Benefit and Consulting Services Compensation Plan (7) EXHIBIT 10.5 United Health Products, Inc. 10624 S. Eastern Ave., Ste. A209 Henderson, NV 89052 Tel: 877-358-3444 June 25, 2015 Dr. Philip Forman Dear Dr. Forman: Your employment agreement of November 10, 2014 is amended as follows. (Note: The sections of the employment agreement not listed below remain unchanged.) Section 1 ? Employment Employee agrees to serve as a medical advisor of the Company
August 19, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
August 17, 2015	NT 10-Q	United Health Products NT 10-Q ueecnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: 06/30/2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition R
August 10, 2015	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders ueec8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 10, 2015 (Date of earliest event reported: August 7, 2015) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction
August 10, 2015	EX-3.1	August 2015 Amendment to Articles of Incorporation (3) ueecex31.htm EXHIBIT 3.1 ROSS MILLER Secretary of State 204 North Carson Street, Suite 1 Carson City, Nevada 89701-4520 (775) 684-5708 Website: www.nvsos.gov Certificate of Amendment (PURSUANT TO NRS 78.385 AND 78.390) USE BLACK INK ONLY - DO NOT HIGHLIGHT ABOVE SPACE IS FOR OFFICE USE ONLY Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporations (Pursuant to NRS 78.385
July 16, 2015	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: (Date of earliest event reported:) July 16, 2015 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporation) (Commissi
July 8, 2015	DEF 14A	United Health Products DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a)of the Securities Exchange Act of 1934 x Filed by the Registrant ? Filed by a Party other than the Registrant Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statem
June 26, 2015	10-K/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH P SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organization) (I.R.S
June 26, 2015	8-K	United Health Products FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 26, 2015 (Date of earliest event reported: June 23, 2015) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporat
June 22, 2015	PRE 14A	United Health Products PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a)of the Securities Exchange Act of 1934 x Filed by the Registrant ? Filed by a Party other than the Registrant Check the appropriate box: x Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statem
May 20, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 ueec10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-
May 20, 2015	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 20, 2015 (Date of earliest event reported: January 12, 2015) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorp
May 18, 2015	NT 10-Q	United Health Products NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: 03/31/2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form
May 6, 2015	10-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organization) (I.R.S.
March 31, 2015	NT 10-K	United Health Products NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: 12/31/2014 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N
January 16, 2015	EX-10.1	January 2015 Services Agreement with Douglas Beplate (6) EXHIBIT 10.1 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (this “Agreement”) dated as of January 12, 2015, by and between UNITED HEALTH PRODUCTS, INC., a Nevada corporation (“Company”) and Douglas Beplate (“Employee”). W I T N E S S E T H: WHEREAS, Company desires to engage the services of Employee and Employee desires to provide the services to Company in connection with Company’s business; and WHER
January 16, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 16, 2015 (Date of earliest event reported: January 12, 2015) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of inco
December 23, 2014	PRE 14A	UEEC / United Health Products, Inc. PRE 14A - - PRE 14A UNITED STATESSE CURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a)of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statem
November 19, 2014	EX-3.1	Articles of Incorporation of the Company dated February 28, 1997 (1) EXHIBIT 3.1
November 19, 2014	EX-3.2	Amendment to Articles of Incorporation. (1) EXHIBIT 3.2
November 19, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODU
November 14, 2014	NT 10-Q	UEEC / United Health Products, Inc. NT 10-Q - - NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: 09/30/2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form
November 13, 2014	EX-10.2	Services Agreement – Nate Knight (4) EXHBIT 10.2 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (this “Agreement”) dated as of November 10, 2014, by and between UNITED HEALTH PRODUCTS, INC., a Nevada corporation (“Company”) and Nate Knight (“Employee”). W I T N E S S E T H: WHEREAS, Company desires to engage the services of Employee and Employee desires to provide the services to Company in connection with Company’s business; and WHEREAS,
November 13, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: November 13, 2014 (Date of earliest event reported: November 10, 2014) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of in
November 13, 2014	EX-10.1	Employment Agreement – Dr. Phillip Forman (4) EXHIBIT 10.1 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (this “Agreement”) dated as of November 10, 2014, by and between UNITED HEALTH PRODUCTS, INC., a Nevada corporation (“Company”) and Phillip Forman (“Employee”). W I T N E S S E T H: WHEREAS, Company desires to engage the services of Employee and Employee desires to provide the services to Company in connection with Company’s business; and WHER
October 21, 2014	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report; date of earliest event reported: October 21, 2014 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporation) (Commiss
August 19, 2014	8-K	Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 19, 2014 (Date of earliest event reported: August 19, 2014) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorp
August 19, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
August 14, 2014	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): X o Form10K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 06/30/2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form
June 17, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 17, 2014 (Date of earliest event reported: June 17, 2014) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporat
June 17, 2014	EX-99.1	United Health Products Inc. Announces Distribution Rights for HemoStyp® Line of Gauze Products EXHIBIT 99.1 United Health Products Inc. Announces Distribution Rights for HemoStyp® Line of Gauze Products Westbury, NY – June 17, 2014 - United Health Products, Inc. (OTCQB: UEEC) announced that it has entered in principle to a multi-year distribution Agreement for its patented HemoStyp® gauze products with AMD-Ritmed. AMD-Ritmed is a privately owned leading provider of healthcare supplies servi
May 20, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
May 16, 2014	NT 10-Q	- NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 03/31/2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form
April 15, 2014	10-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2013 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organization) (I.R.S.
March 31, 2014	NT 10-K	- NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: 12/31/2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form
March 4, 2014	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 4, 2014 (Date of earliest event reported: March 3, 2014) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporat
February 21, 2014	EX-99.1	United Health Products Inc. to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference on March 3rd EXHIBIT 99.1 News United Health Products Inc. to Present at 24th Annual Wall Street Analyst Forum Institutional Investor Conference on March 3rd Westbury, NY – February 21, 2014 - United Health Products, Inc. (OTCQB: UEEC), a developer and marketer of wound care products and technologies in the healthcare sector, announced that Douglas Beplate, COO, will present at the 24th Annual Wall Street Anal
February 21, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 21, 2014 (Date of earliest event reported: February 21, 2014) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of in
December 20, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 19, 2013 (Date of earliest event reported: December 19, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of in
December 20, 2013	EX-99.1	United Health Products Inc. Receives Initial HemoStyp® Order for Australian Market Receives Australian Regulatory Approval EXHIBIT 99.1 NEWS United Health Products Inc. Receives Initial HemoStyp® Order for Australian Market Receives Australian Regulatory Approval Westbury, NY – December 19, 2013 - United Health Products, Inc. (OTCQB: UEEC) announced that its Australian distributor, Critical Health Products Ltd., has placed an initial order for HemoStyp® gauze products. The order was placed following Critical Health Pr
December 2, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 2, 2013 (Date of earliest event reported: November 26, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of inc
November 14, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODU
September 26, 2013	EX-99.1	United Health Products Inc.’s Exclusive Dental Marketing Agent, Sinc Ventures, L.L.C., Receives Vendor Status To Supply HemoStyp™ Gauze To Henry Schein, Inc. EXHIBIT 99.1 NEWS United Health Products Inc.’s Exclusive Dental Marketing Agent, Sinc Ventures, L.L.C., Receives Vendor Status To Supply HemoStyp™ Gauze To Henry Schein, Inc. Westbury, NY – September 26, 2013 - United Health Products, Inc. (OTCQB: UEEC) announced that its HemoStyp™ gauze will be distributed to the dental industry by Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider
September 26, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 26, 2013 (Date of earliest event reported: September 26, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of
September 17, 2013	EX-99.1	News Exhibit 99.1 News United Health Products Receives Notice of Allowance for Patent Application for HemoStypeTM Gauze Product – Anticipates First Orders from Dental and Medical Markets Westbury, NY - September 16, 2013 - United Health Products, Inc. (OTCQB: UEEC) announced that it has received formal notification of allowance of its patent application from the U.S. Patent Office for its hemostatic ga
September 17, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 17, 2013 (Date of earliest event reported: September 16, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of
September 10, 2013	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 10, 2013 (Date of earliest event reported: September 10, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of
August 19, 2013	S-8	- FORM S-8 As filed with the Securities and Exchange Commission on August 19, 2013. Registration No. 333- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 UNITED HEALTH PRODUCTS, INC. (Exact Name of Issuer as specified in its Charter) Nevada 84-1517723 (State of other Jurisdiction Incorporation or Organization) (I.R.S. Employer Identif
August 14, 2013	EX-99.1	UNITED HEALTH PRODUCTS, INC. 2013 EMPLOYEE BENEFIT AND CONSULTING SERVICES COMPENSATION PLAN EXHIBIT 99.1 UNITED HEALTH PRODUCTS, INC. 2013 EMPLOYEE BENEFIT AND CONSULTING SERVICES COMPENSATION PLAN SECTION 1. INTRODUCTION 1.1 Establishment. United Health Products, Inc., a Nevada corporation (the ?Company?), hereby establishes a plan of long-term stock-based compensation incentives for selected Eligible Participants (defined below) of the Company and its affiliated corporations. This plan
August 14, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
August 14, 2013	EX-10.1	1 EXHIBIT 10.1 1 2
August 14, 2013	EX-10.2	CONSULTING AGREEMENT EXHIBIT 10.2 CONSULTING AGREEMENT This Agreement is made effective as of the 8th day of August, 2013, by and between United Health Products, Inc., ("the Company") a corporation duly organized and existing under the laws of Nevada, with offices at c/o Morse & Morse, PLLC, 1400 Old Country Road, Suite 302, Westbury, NY 11590 and Douglas Beplate ("the Consultant") whose address is on file with the Co
July 22, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 19, 2013 (Date of earliest event reported: July 18, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporat
July 22, 2013	EX-99.1	United Health Products, Inc. Initiates Investor Relations EXHIBIT 99.1 United Health Products, Inc. Initiates Investor Relations Bibicoff + MacInnis to Implement Investment Community Outreach Program Press Release: United Health Products, Inc. – Thu, Jul 18, 2013 8:24 AM EDT COLTS NECK, N.J.-(BUSINESS WIRE)- United Health Products, Inc. (OTCQB: UEEC) announced today that it has engaged Bibicoff + MacInnis, Inc., a full service investor relations and stra
June 19, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 ueec10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number:
June 19, 2013	10-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRO SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2012 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organization) (I.R.S.
June 19, 2013	10-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2011 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRO SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2011 COMMISSION FILE NUMBER: 814-00717 UNITED HEALTH PRODUCTS, INC. (Exact name of Registrant as specified in its charter) Nevada 84-1517723 (State of jurisdiction of incorporation or organization) (I.R.S.
June 19, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
June 19, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 ueec10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-
June 19, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 ueec10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-0
May 23, 2013	8-K	- FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 23, 2013 (Date of earliest event reported: December 19, 2012) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorpo
May 23, 2013	8-K	Other Events - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 23, 2013 (Date of earliest event reported: April 3, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporati
May 23, 2013	8-K/A	Other Events - FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 23, 2013 (Date of earliest event reported: April 3, 2013) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorpora
December 12, 2012	8-K	- FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 5, 2012 (Date of earliest event reported: December 12, 2012) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of in
December 3, 2012	8-K	- FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 3, 2012 (Date of earliest event reported: August 6, 2012) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-27781 84-1517723 (State or other jurisdiction of incorp
December 3, 2012	EX-16.1	Rosenberg Rich Baker Berman & Company Exhibit 16.1 Rosenberg Rich Baker Berman & Company 265 Davidson Avenue, Suite 210 Somerset, NJ 08873 November 28, 2012 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: United Health Products, Inc. To Whom It May Concern: We have read the statements that we understand United Health Products, Inc. will include under Item 4.01 of its Form 8-K regarding the change of au
June 19, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K United Health Products, Inc. (Form: 8-K, Received: 03/02/2012 16:54:26) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2012 UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-007
April 3, 2012	NT 10-K	- FORM NT 10-K United EcoEnergy Corp. (Form: NT 10-Q, Received: 11/16/2009 16:09:25) U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [x ]Form 10-KS [ ]Form 20-F [ ]Form 11-K []Form 10-Q [ ]Form N-SAR For Period Ended: December 31, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tr
March 2, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
November 21, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 o TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODU
November 14, 2011	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 814-00717 NOTIFICATION OF LATE FILING CUSIP Number 910203 10 8 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR For Period Ended: September 30, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 1
September 12, 2011	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 o TRANSITION RE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED
August 22, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
August 16, 2011	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 814-00717 NOTIFICATION OF LATE FILING CUSIP Number 910203 10 8 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form N-SAR For Period Ended: June 30, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o
June 2, 2011	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 1, 2011 Date of Report (Date of earliest event reported) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 94-1517723 (State or other jurisdiction of incorporation) (Commission
May 16, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCTS,
April 15, 2011	EX-21	United Health Products, Inc. Subsidiaries Exhibit 21 United Health Products, Inc. Subsidiaries Wholly-Owned Epic Wound Care, Inc - Florida Other City 24/7 LLC (10%) - Nevada
April 15, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 [ ] TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODUCT
April 1, 2011	NT 10-K	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 814-00717 NOTIFICATION OF LATE FILING CUSIP Number 910203 10 8 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number 814-00717 NOTIFICATION OF LATE FILING CUSIP Number 910203 10 8 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR For Period Ended: December 31, 2010 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10
March 14, 2011	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 8, 2011 Date of Report (Date of earliest event reported) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporation) (Commission
March 14, 2011	EX-10.1	SETTLEMENT AND RELEASE AGREEMENT Exhibit 10.1 SETTLEMENT AND RELEASE AGREEMENT This Global Settlement and Release Agreement (?Agreement?) is entered into as of the 8th day of March 2011 by and between United Health Products, Inc. (formerly United EcoEnergy Corp.), a Nevada corporation having its principal place of business in New York, New York (?United?); Epic Wound Care, Inc., a Florida corporation having its principal place of
March 1, 2011	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 23, 2011 Date of Report (Date of earliest event reported) UNITED HEALTH PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 814-00717 84-1517723 (State or other jurisdiction of incorporation) (Commis
February 17, 2011	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.5)* United Health Products, Inc. COMMON STOCK (Title of Class of Securities) (CUSIP Number) February 16, 20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.5)* United Health Products, Inc. COMMON STOCK (Title of Class of Securities) 910203108 (CUSIP Number) February 16, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i
November 22, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED HEALTH PRODU
November 16, 2010	NT 10-Q	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): []Form 10-KS [ ]Form 20-F [ ]Form 11-K [x]Form 10-Q [ ]Form N-SAR For Period Ended: September 30, 2010 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For t
August 17, 2010	N-54C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-54C NOTIFICATION OF WITHDRAWAL OF ELECTION TO BE SUBJECT TO SECTIONS 55 THROUGH65 OF THE INVESTMENT COMPANY ACT OF 1940, FILED PURSUANT TO SECTION 54(C) OF THEINVESTMENT C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-54C NOTIFICATION OF WITHDRAWAL OF ELECTION TO BE SUBJECT TO SECTIONS 55 THROUGH65 OF THE INVESTMENT COMPANY ACT OF 1940, FILED PURSUANT TO SECTION 54(C) OF THEINVESTMENT COMPANY ACT OF 1940 The undersigned business development company hereby notifies the Securities and Exchange Commission that it withdraws its election
August 16, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2010 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 814-00717 UNITED ECOENERGY CORP. (
August 3, 2010	EX-10.2	CORPORATE SPONSORSHIP AGREEMENT Exhibit 10.2 CORPORATE SPONSORSHIP AGREEMENT This Agreement is made effective November 1, 2010 between the American Diabetes Association, an Ohio non-profit corporation with its principal office located at 1701 N. Beauregard Street, Alexandria, Virginia 22311 ("ADA"), and the Epic Wound Care, Inc. ("Company" or "Epic Wound Care"), a Nevada corporation, with its principal place of business at 1365
August 3, 2010	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 17, 2010 Date of Report (Date of earliest event reported) UNITED ECOENERGY CORP. (Exact name of registrant as specified in its charter) NEVADA 814-00717 84-1517723 (State or other jurisdiction of incorporation) (Commission File
August 3, 2010	EX-10.1	Filed as a PDF Reference Exhibit 10.1 Filed as a PDF Reference
August 3, 2010	EX-10.1	EX-10.1 )C':"~"{'~:;" ....• }•. ~.).•.... ~ ::'·'~ -,"r .•. ).• :::u·~ f.. ~~;)"'{ ~"l'(:"':''''''''''' :;r~:'(~}.,,~,.~, .• :~(· l·•.. ··• '~·.A >:.:.:: •• ' ••.l:r.· ... {~(~>>..t.:' •..••••.•••~••.•• !" $.,,:..'U. ••• Nl",,«c:.,H«J ·•••. :<.:.Y:. T~)~:ri~.: ~;.th!i~~~~~nn .~\:"~« ..{}~Hg:{t~~ }(~·::~~..~·~.(~tk: S~1tin.GmltC Vds.(: k!Ks .•.. ~:n ;>.$ KRX-!)3). (tkrd~«!n~;: ri:'r~:mA ~i; ~:.'" "l<) KIZX
July 7, 2010	DEFA14C	IMPORTANT NOTICE REGARDING THE AVAILABILITY OF INFORMATION STATEMENT, DATED JULY 7, 2010 WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY. UNITED ECOENERGY CORP. 120 Wall Street Suite 2401 New York, New York 10005 IMPORTANT NOTICE REGARDING THE AVAILABILITY OF INFORMATION STATEMENT, DATED JULY 7, 2010 WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

UEEC / United Health Products, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)